Persistence Market Research Released New Market Report on “Global
Market Study on Obesity Surgery Devices: Asia-Pacific to Witness
Highest Growth by 2020” the global obesity surgery devices market
was valued at USD 1,432.4 million in 2014 and is expected to grow at
a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD
2,489.5 million in 2020.
Globally, the obesity surgery devices market is witnessing
significant growth due to increasing obesity epidemic and increasing
sedentary lifestyle and junk food habits. Increasing prevalence of
obesity among children and adults is posing a threat in both
developed and developing nations. Excess body weight directly
contributes to increasing risk of stroke, heart diseases, type-2
diabetes and some forms of cancer. Obesity surgery is a broadly
available treatment for persons with severe and complex obesity.
However, inadequate insurance coverage for the procedure and
excessive cost of surgery often makes it unaffordable. In addition,
selective nature of obesity surgery, due to its complications,
restricts growth of obesity surgery devices market. The global
obesity surgery device market is estimated at USD 1,432.4 million in
2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to
reach USD 2,489.5 million in 2020.
Request to view table of content @
North America is facing serious public health problems due to
obesity. The U.S. accounted for 13% of obese persons worldwide in
2013. Similarly, according to the Centers for Disease Control and
Prevention (CDC), 24.5% of Americans were suffering from obesity in
2004 and this increased to 35.7% in 2011. In 2011, Roux-en-Y gastric
bypass was the most common procedure in North America.
In Europe, obesity is a major public health challenge in Europe.
According to the Organization for Economic Co-operation and
Development (OECD) in 2010, approximately 52% of the population in
the European Union was obese or overweight.
Request Sample Report @
However, in Asia obesity has reached epidemic proportions in many
countries in Asia Pacific. South East Asia and Western Pacific
regions are facing an epidemic of obesity-associated diseases such as
cardiovascular disorders and diabetes. China and India accounted for
around 15% of the world’s obese population worldwide in 2013.
Johnson & Johnson, Medtronic, Inc., Apollo Endosurgery Inc,
Aspire Bariatrics, Spatz FGIA Inc., MetaCure and IntraPace Inc are
some of the major players of obesity surgery devices market.
Buy Obesity Surgery Devices Market @
No comments:
Post a Comment